FORM 8-A/A
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Psychemedics Corporation
(exact name of registrant as specified in its charter)
|
|
|
Delaware
(State of incorporation or organization)
|
|
58-1701987
(I.R.S. Employer Identification No.) |
|
|
|
125 Nagog Park, Acton, Massachusetts
(Address of principal executive offices)
|
|
01720
(Zip Code) |
Securities to be registered pursuant to Section 12(b) of the Act:
|
|
|
Title of each class
to be so registered
|
|
Name of each exchange on which
each class is to be registered |
|
|
|
Common Stock, $.005 par value
|
|
The NASDAQ Stock Market, LLC |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of
the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. þ
If this form relates to the registration of a class of securities pursuant to Section 12(g) of
the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. o
Securities
Act registration statement file number to which this form relates: _________ (if
applicable)
Securities to be registered pursuant to Section 12(g) of the Act:
None.
Item 1. Description of Registrants Securities to be Registered.
The total authorized capital stock of the Registrant sought to be registered hereunder
consists of fifty million (50,000,000) shares of Common Stock, $.005 par value. The Registrant
also has authorized eight hundred seventy-two thousand five hundred twenty-one (872,521) shares of
Preferred Stock. The holders of outstanding shares of the Registrants Common Stock are entitled
to receive dividends out of the assets legally available therefor at such times and in such amounts
as the Board of Directors may from time to time determine, subject to any preferences that the
Board of Directors may from time to time prescribe for the holders of Preferred Stock. All shares
of Common Stock have equal voting rights and, when validly issued and outstanding, have one vote
per share in all matters to be voted upon by holders of Common
Stock. The holders of shares of Common Stock do not have cumulative voting rights. Upon
liquidation of the Registrant, stockholders are entitled to receive ratably any assets available
for distribution to stockholders after payment of all obligations of the Registrant and the payment
to the holders of Preferred Stock of the specific preferential amounts which they are entitled to
receive upon such liquidation. The holders of Common Stock have no preemptive, subscription,
redemption or conversion rights.
The Board of Directors has the authority to issue the Preferred Stock in one or more series
and to fix the rights, preferences, privileges and restrictions thereof, including dividend rights,
dividend rates, conversion rights, voting rights, terms of redemption, redemption prices,
liquidation preferences and the number of shares constituting any series or the designation of such
series, without further vote or action by the stockholders. The issuance of Preferred Stock may
have the effect of delaying, deferring or preventing a change in control of the Registrant without
further action by the stockholders and may adversely affect the voting and other rights of the
holders of Common Stock. The issuance of Preferred Stock with voting and conversion rights may
adversely affect the voting power of the holders of Common Stock, including the loss of voting
control to others. As of the date of this Registration Statement, the Company has no Preferred
Stock outstanding. The Company currently has no plans to issue any Preferred Stock.
Item 2. Exhibits.
|
|
|
Number
|
|
EXHIBIT TITLE |
|
|
|
1
|
|
Amended and Restated Certificate of Incorporation of the Registrant (incorporated by
reference from Exhibit 1 to the Registrants Registration Statement on Form 8-A filed on July
31, 2002). |
|
|
|
2
|
|
By-laws of Psychemedics Corporation (incorporated by reference from Exhibit 3.6 to the
Registrants Annual Report on Form 10-K for the fiscal year ended December 31, 2001) |
|
|
|
3
|
|
Form of stock certificate representing share of Common Stock, $.005 par value per share
(incorporated by reference from Exhibit 3 to the Registrants Registration Statement on Form
8-A filed on July 31, 2002). |
2
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the
registrant has duly caused this registration statement to be signed on its behalf by the
undersigned, thereto duly authorized.
|
|
|
|
|
Date September 22, 2008 |
PSYCHEMEDICS CORPORATION
|
|
|
By: |
/s/ Raymond C. Kubacki
|
|
|
|
Raymond C. Kubacki, |
|
|
|
Chairman and Chief Executive Officer |
|
|
3